<DOC>
	<DOCNO>NCT02648282</DOCNO>
	<brief_summary>This study look whether combine cyclophosphamide , pembrolizumab ( antibody block negative signal T cell ) , GVAX ( pancreatic cancer vaccine ) , SBRT ( focused radiation ) effective ( anti-tumor activity ) safe patient locally advanced pancreatic cancer .</brief_summary>
	<brief_title>Study With CY , Pembrolizumab , GVAX , SBRT Patients With Locally Advanced Pancreatic Cancer</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Pembrolizumab</mesh_term>
	<criteria>1. locally advanced pancreatic adenocarcinoma 2 . Patients must receive mFOLFIRINOX Gemcitabine/ Abraxane base chemotherapy 4 cycle last dose therapy 25 week study enrollment . 3 . No metastatic disease 4 . ECOG Performance Status 0 1 5 . Adequate organ function define studyspecified laboratory test 6 . Patients must able fiducials place SBRT 7 . Must use acceptable form birth control study 8 . Signed informed consent form 9 . Willing able comply study procedures 1 . Patients mFOLFIRINOX gemcitabine/abraxane therapy 49 day 2 . Patients one line chemotherapy 3 . Patients uncontrolled intercurrent illness , include limited ongoing active infection , systematic congestive heart failure , unstable angina pectoris , cardiac arrhythmia psychiatric condition would limit compliance study requirement 4 . Patient prior treatment IL2 , interferon , antiPD1 , antiPDL1 , antiPDL2 , antiCD137 , antiOX40 , antiCD40 , antiCTLA4 antibody 5 . Patients receive active immunosuppressive agent chronic use systemic corticosteroid within 14 day prior first dose study drug 6 . Patients receive growth factor , include limited granulocytecolony stimulate factor ( GCSF ) , granulocyte macrophagecolony stimulate factor ( GMCSF ) , erythropoietin , etc . within 14 day study drug administration 7 . Patients history autoimmune disease : inflammatory bowel disease , ( include ulcerative colitis Crohn 's Disease ) , rheumatoid arthritis , systemic progressive sclerosis ( scleroderma ) , systemic lupus erythematous ( SLE ) autoimmune vasculitis , CNS motor neuropathy consider autoimmune origin . 8 . Patients known history infection HIV , hepatitis B , hepatitis C 9 . Patients evidence interstitial lung disease 10 . Patients home oxygen 11 . Patients oxygen saturation &lt; 92 % room air pulse oximetry 12 . Pregnant lactate 13 . Conditions , include alcohol drug dependence , intercurrent illness would affect patient 's ability comply study visit procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>vaccine</keyword>
	<keyword>immunotherapy</keyword>
	<keyword>antibody</keyword>
	<keyword>PD-1</keyword>
	<keyword>radiation</keyword>
</DOC>